Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study.
Danilo GaliziaAndrea MilaniElena GeunaRossella MartinelloCeleste CagnazzoManuela ForestoVirginia LongoPaola BerchiallaGianfranca SolinasAdele CaloriBruna GrassoChiara VolponeGisella BertolaGisella ParolaGiancarla TealdiPiero Luigi GiulianoAnna Maria BallariMassimo AgliettaFilippo MontemurroPublished in: Cancer medicine (2018)
Self-reporting TSE duration is feasible using a CTCAE-derived questionnaire. As doctors tend to underestimate TSE incidence and duration, patient-reported outcomes should be incorporated into clinical practice, perhaps using eHealth technologies, to harness their potential to better estimate total TSE burden.